Home Cart Sign in  
Chemical Structure| 347323-96-0 Chemical Structure| 347323-96-0

Structure of ITX3
CAS No.: 347323-96-0

Chemical Structure| 347323-96-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

ITX3 is a specific and nontoxic inhibitor of the TrioN (N-terminal GEF domain of the multidomain Trio protein) with IC50 of 76 μM and inhibits TrioN-stimulated RhoG exchange in vitro.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of ITX3

CAS No. :347323-96-0
Formula : C22H17N3OS
M.W : 371.45
SMILES Code : O=C1N2C(S/C1=C\C3=C(C)N(C4=CC=CC=C4)C(C)=C3)=NC5=CC=CC=C52
MDL No. :MFCD02629172

Safety of ITX3

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

Description
ITX3 emerges as a specific and non-toxic inhibitor of TrioN, the N-terminal GEF domain of the multi-domain Trio protein, displaying an IC50 value of 76 μM. This inhibitor is noted for its potential in research applications[1].[2].

In Vitro:

Cell Line
Concentration Treated Time Description References
MDCK cells 100 µM ITX3 inhibits the Rac1-GEF activity of Trio RhoGEF, reverses Rac1 activation in Tara-KD cells, and up-regulates E-cadherin protein levels PMC3080255
MRC5 cells 100 μM 30 min Inhibition of Trio expression significantly reduced RhoG activation, decreased the number of cells forming CDRs, and reduced the average area of CDRs. PMC5491185
A7r5 cells 100 μM 30 min Inhibition of Trio expression significantly reduced RhoG activation, decreased the number of cells forming CDRs, and reduced the average area of CDRs. PMC5491185
human pulmonary artery ECs (HPA ECs) 50 µM 30 min Inhibited the interaction of Trio with Rac1, reducing VE-cadherin adhesion area at junctions PMC6314553
hippocampal neurons 100 nM 45 min Inhibition of Trio GEF1 activity, significantly decreased Rac activity, and promoted growth cone collapse PMC3360552
Human umbilical vein endothelial cells (HUVECs) 75 µM 2 h To inhibit TrioGEF1 activity and study its effect on flow-induced endothelial cell alignment. Results showed that ITX3-treated cells aligned normally under long-term flow conditions, indicating that TrioGEF1 activity is not required for flow-induced EC alignment. PMC5491183

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.69mL

0.54mL

0.27mL

13.46mL

2.69mL

1.35mL

26.92mL

5.38mL

2.69mL

References

 

Historical Records

Categories